Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of Phosphodiesterase-5 Inhibitor Tadalafil in Eisenmenger Syndrome - A Randomised, Placebo Controlled, Double Blind, Crossover Study

NCT01200732 is registered in ClinicalTrials.gov with Govind Ballabh Pant Hospital as lead sponsor.

NCT NCT01200732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01200732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of Phosphodiesterase-5 Inhibitor Tadalafil in Eisenmenger Syndrome - A Randomised, Placebo Controlled, Double Blind, Crossover Study
Lead sponsor
Govind Ballabh Pant Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
July 31, 2010
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eisenmenger syndrome